List of works - Michael A Eller

A de novo approach to inferring within-host fitness effects during untreated HIV-1 infection

scientific article published on 03 June 2020

A double-blind randomized phase I clinical trial targeting ALVAC-HIV vaccine to human dendritic cells

scientific article published on 16 September 2011

A phase 1/2 study of a multiclade HIV-1 DNA plasmid prime and recombinant adenovirus serotype 5 boost vaccine in HIV-Uninfected East Africans (RV 172).

scientific article

A transmission-virulence evolutionary trade-off explains attenuation of HIV-1 in Uganda

scientific article

A vaccine-induced gene expression signature correlates with protection against SIV and HIV in multiple trials

scientific article published on 01 August 2019

Adjuvanted HIV-1 vaccine promotes antibody-dependent phagocytic responses and protects against heterologous SHIV challenge

scientific article published on 03 September 2020

B cell depletion in HIV-1 subtype A infected Ugandan adults: relationship to CD4 T cell count, viral load and humoral immune responses

scientific article

Brief Report: Differential Associations of Interleukin 6 and Intestinal Fatty Acid-Binding Protein With Progressive Untreated HIV-1 Infection in Rakai, Uganda.

scientific article

Circulating HIV-Specific Interleukin-21(+)CD4(+) T Cells Represent Peripheral Tfh Cells with Antigen-Dependent Helper Functions

scientific article published on 11 January 2016

Cooperativity of HIV-Specific Cytolytic CD4 T Cells and CD8 T Cells in Control of HIV Viremia

scientific article published on 13 May 2015

Correction: Rare HIV-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infection

scientific article published on 14 September 2017

Detection of HIV-1 neutralizing antibodies in a human CD4⁺/CXCR4⁺/CCR5⁺ T-lymphoblastoid cell assay system

scientific article

Differential Inhibitory Receptor Expression on T Cells Delineates Functional Capacities in Chronic Viral Infection

scientific article published on 13 September 2017

Differential loss of invariant natural killer T cells and FoxP3⁺ regulatory T cells in HIV-1 subtype A and subtype D infections

scientific article published on July 2013

Distinct biomarker signatures in HIV acute infection associate with viral dynamics and reservoir size.

scientific article

Dynamic MAIT cell response with progressively enhanced innateness during acute HIV-1 infection

scientific article published on 14 January 2020

Effect of human immunodeficiency virus Type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection

scientific article published on March 2008

Elevated natural killer cell activity despite altered functional and phenotypic profile in Ugandans with HIV-1 clade A or clade D infection

scientific article published on August 2009

Evolution of HIV-1 within untreated individuals and at the population scale in Uganda

article

Expansion of Inefficient HIV-Specific CD8 T Cells during Acute Infection

scientific article published on 3 February 2016

First-in-Human Randomized Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara Vector.

scientific article published on 13 April 2018

HIV Type 1 Disease Progression to AIDS and Death in a Rural Ugandan Cohort Is Primarily Dependent on Viral Load Despite Variable Subtype and T-Cell Immune Activation Levels

scientific article published on 17 November 2014

HIV-1 viral subtype differences in the rate of CD4+ T-cell decline among HIV seroincident antiretroviral naive persons in Rakai district, Uganda

scientific article

High-throughput high-resolution class I HLA genotyping in East Africa

scientific article

Higher HIV-1 incidence and genetic complexity along main roads in Rakai District, Uganda

scientific article published on December 2006

Human immunodeficiency virus type 1 infection is associated with increased NK cell polyfunctionality and higher levels of KIR3DL1+ NK cells in ugandans carrying the HLA-B Bw4 motif

scientific article

Impaired natural killer cell responses are associated with loss of the highly activated NKG2A(+)CD57(+)CD56(dim) subset in HIV-1 subtype D infection in Uganda

scientific article

Induction of HIV-specific functional immune responses by a multiclade HIV-1 DNA vaccine candidate in healthy Ugandans

scientific article published on 17 September 2007

Innate and adaptive immune responses both contribute to pathological CD4 T cell activation in HIV-1 infected Ugandans

scientific article

Large-scale human immunodeficiency virus rapid test evaluation in a low-prevalence ugandan blood bank population

scientific article

Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: a retrospective cohort study

scientific article

Longitudinal Analysis of Peripheral and Colonic CD161<sup>+</sup> CD4<sup>+</sup> T Cell Dysfunction in Acute HIV-1 Infection and Effects of Early Treatment Initiation

scientific article published on 11 December 2020

Modulation of Vaccine-Induced CD4 T Cell Functional Profiles by Changes in Components of HIV Vaccine Regimens in Humans

article

Preferential infection of human Ad5-specific CD4 T cells by HIV in Ad5 naturally exposed and recombinant Ad5-HIV vaccinated individuals

scientific article

Preservation of Peripheral T Follicular Helper Cell Function in HIV Controllers

scientific article published on 3 May 2017

Prospective Study of Acute HIV-1 Infection in Adults in East Africa and Thailand

scientific article

Quality monitoring of HIV-1-infected and uninfected peripheral blood mononuclear cell samples in a resource-limited setting

scientific article

RV144 HIV-1 vaccination impacts post-infection antibody responses

scientific article published on 08 December 2020

Randomized, Double-Blind Evaluation of Late Boost Strategies for HIV-Uninfected Vaccine Recipients in the RV144 HIV Vaccine Efficacy Trial

scientific article

Rare HIV-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infection

scientific article published on 31 July 2017

Reference intervals in healthy adult Ugandan blood donors and their impact on conducting international vaccine trials

scientific article

Relatively low HIV infection rates in rural Uganda, but with high potential for a rise: a cohort study in Kayunga District, Uganda

scientific article

Safety and Immunogenicity of PENNVAX®-G DNA Prime Administered by Biojector® 2000 or CELLECTRA® Electroporation Device with Modified Vaccinia Ankara-CMDR Boost

scientific article published on 2 September 2017

Safety and efficacy of VRC01 broadly neutralising antibodies in adults with acutely treated HIV (RV397): a phase 2, randomised, double-blind, placebo-controlled trial

scientific article published on 15 April 2019

Safety and immunogenicity of Ad26 and MVA vaccines in acutely treated HIV and effect on viral rebound after antiretroviral therapy interruption

scientific article published on 23 March 2020

Sex and Urbanicity Contribute to Variation in Lymphocyte Distribution across Ugandan Populations

scientific article published on 5 January 2016

Single-cell level response of HIV-specific and cytomegalovirus-specific CD4 T cells correlate with viral control in chronic HIV-1 subtype A infection

scientific article published in September 2012

Terminal Effector CD8 T Cells Defined by an IKZF2+IL-7R- Transcriptional Signature Express FcγRIIIA, Expand in HIV Infection, and Mediate Potent HIV-Specific Antibody-Dependent Cellular Cytotoxicity

scientific article published on 13 September 2019

The CD4-CD8- MAIT cell subpopulation is a functionally distinct subset developmentally related to the main CD8+ MAIT cell pool

scientific article published on 15 November 2018

Transcriptomic signatures of NK cells suggest impaired responsiveness in HIV-1 infection and increased activity post-vaccination.

scientific article published on 23 March 2018

List of works by Michael A Eller

A de novo approach to inferring within-host fitness effects during untreated HIV-1 infection

A double-blind randomized phase I clinical trial targeting ALVAC-HIV vaccine to human dendritic cells

A phase 1/2 study of a multiclade HIV-1 DNA plasmid prime and recombinant adenovirus serotype 5 boost vaccine in HIV-Uninfected East Africans (RV 172).

A transmission-virulence evolutionary trade-off explains attenuation of HIV-1 in Uganda

A vaccine-induced gene expression signature correlates with protection against SIV and HIV in multiple trials

Adjuvanted HIV-1 vaccine promotes antibody-dependent phagocytic responses and protects against heterologous SHIV challenge

B cell depletion in HIV-1 subtype A infected Ugandan adults: relationship to CD4 T cell count, viral load and humoral immune responses

Brief Report: Differential Associations of Interleukin 6 and Intestinal Fatty Acid-Binding Protein With Progressive Untreated HIV-1 Infection in Rakai, Uganda.

Circulating HIV-Specific Interleukin-21(+)CD4(+) T Cells Represent Peripheral Tfh Cells with Antigen-Dependent Helper Functions

Cooperativity of HIV-Specific Cytolytic CD4 T Cells and CD8 T Cells in Control of HIV Viremia

Correction: Rare HIV-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infection

Detection of HIV-1 neutralizing antibodies in a human CD4⁺/CXCR4⁺/CCR5⁺ T-lymphoblastoid cell assay system

Differential Inhibitory Receptor Expression on T Cells Delineates Functional Capacities in Chronic Viral Infection

Differential loss of invariant natural killer T cells and FoxP3⁺ regulatory T cells in HIV-1 subtype A and subtype D infections

Distinct biomarker signatures in HIV acute infection associate with viral dynamics and reservoir size.

Dynamic MAIT cell response with progressively enhanced innateness during acute HIV-1 infection

Effect of human immunodeficiency virus Type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection

Elevated natural killer cell activity despite altered functional and phenotypic profile in Ugandans with HIV-1 clade A or clade D infection

Evolution of HIV-1 within untreated individuals and at the population scale in Uganda

Expansion of Inefficient HIV-Specific CD8 T Cells during Acute Infection

First-in-Human Randomized Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara Vector.

HIV Type 1 Disease Progression to AIDS and Death in a Rural Ugandan Cohort Is Primarily Dependent on Viral Load Despite Variable Subtype and T-Cell Immune Activation Levels

HIV-1 viral subtype differences in the rate of CD4+ T-cell decline among HIV seroincident antiretroviral naive persons in Rakai district, Uganda

High-throughput high-resolution class I HLA genotyping in East Africa

Higher HIV-1 incidence and genetic complexity along main roads in Rakai District, Uganda

Human immunodeficiency virus type 1 infection is associated with increased NK cell polyfunctionality and higher levels of KIR3DL1+ NK cells in ugandans carrying the HLA-B Bw4 motif

Impaired natural killer cell responses are associated with loss of the highly activated NKG2A(+)CD57(+)CD56(dim) subset in HIV-1 subtype D infection in Uganda

Induction of HIV-specific functional immune responses by a multiclade HIV-1 DNA vaccine candidate in healthy Ugandans

Innate and adaptive immune responses both contribute to pathological CD4 T cell activation in HIV-1 infected Ugandans

Large-scale human immunodeficiency virus rapid test evaluation in a low-prevalence ugandan blood bank population

Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: a retrospective cohort study

Longitudinal Analysis of Peripheral and Colonic CD161<sup>+</sup> CD4<sup>+</sup> T Cell Dysfunction in Acute HIV-1 Infection and Effects of Early Treatment Initiation

Modulation of Vaccine-Induced CD4 T Cell Functional Profiles by Changes in Components of HIV Vaccine Regimens in Humans

Preferential infection of human Ad5-specific CD4 T cells by HIV in Ad5 naturally exposed and recombinant Ad5-HIV vaccinated individuals

Preservation of Peripheral T Follicular Helper Cell Function in HIV Controllers

Prospective Study of Acute HIV-1 Infection in Adults in East Africa and Thailand

Quality monitoring of HIV-1-infected and uninfected peripheral blood mononuclear cell samples in a resource-limited setting

RV144 HIV-1 vaccination impacts post-infection antibody responses

Randomized, Double-Blind Evaluation of Late Boost Strategies for HIV-Uninfected Vaccine Recipients in the RV144 HIV Vaccine Efficacy Trial

Rare HIV-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infection

Reference intervals in healthy adult Ugandan blood donors and their impact on conducting international vaccine trials

Relatively low HIV infection rates in rural Uganda, but with high potential for a rise: a cohort study in Kayunga District, Uganda

Safety and Immunogenicity of PENNVAX®-G DNA Prime Administered by Biojector® 2000 or CELLECTRA® Electroporation Device with Modified Vaccinia Ankara-CMDR Boost

Safety and efficacy of VRC01 broadly neutralising antibodies in adults with acutely treated HIV (RV397): a phase 2, randomised, double-blind, placebo-controlled trial

Safety and immunogenicity of Ad26 and MVA vaccines in acutely treated HIV and effect on viral rebound after antiretroviral therapy interruption

Sex and Urbanicity Contribute to Variation in Lymphocyte Distribution across Ugandan Populations

Single-cell level response of HIV-specific and cytomegalovirus-specific CD4 T cells correlate with viral control in chronic HIV-1 subtype A infection

Terminal Effector CD8 T Cells Defined by an IKZF2+IL-7R- Transcriptional Signature Express FcγRIIIA, Expand in HIV Infection, and Mediate Potent HIV-Specific Antibody-Dependent Cellular Cytotoxicity

The CD4-CD8- MAIT cell subpopulation is a functionally distinct subset developmentally related to the main CD8+ MAIT cell pool

Transcriptomic signatures of NK cells suggest impaired responsiveness in HIV-1 infection and increased activity post-vaccination.